13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      m 6A RNA Methylation Regulators Contribute to Malignant Progression and Have Clinical Prognostic Impact in Gastric Cancer

      research-article
      1 , 2 , 3 , *
      Frontiers in Oncology
      Frontiers Media S.A.
      gastric cancer, m6A, TCGA, epigenetic modification, FTO

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          N6-methyladenosine (m 6A) is the most common form of mRNA modification, and is dynamically regulated by the m 6A RNA methylation regulators. However, little is known about m 6A in gastric cancer. The aim of this work is to investigate the effects of m 6A RNA methylation regulators in gastric cancer. Here, we found that most of the 13 main m 6A RNA methylation regulators are higher expressed in 375 patients with gastric cancer. We identified two subgroups of gastric cancer (cluster1 and 2) by applying consensus clustering to m 6A RNA methylation regulators. Compared with the cluster1 subgroup, the cluster2 subgroup correlates with a poorer prognosis, and most of the 13 main m 6A RNA methylation regulators are higher expressed in cluster2. Moreover, the cancer-specific pathways are also significantly enriched in the cluster2 subgroup. This finding indicates that m 6A RNA methylation regulators are closely associated with gastric cancer. Based on this finding, we derived a risk signature, using 3 m 6A RNA methylation regulators (FTO, RBM15, ALKBH5), that is not only an independent prognostic marker but can also predict the clinicopathological features of gastric cancer. Moreover, FTO is higher expressed in high risk scores subtype in gastric cancer. Thus, this first finding provide us clues to understand epigenetic modification of RNA in gastric cancer.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Methylated nucleotides block 5' terminus of HeLa cell messenger RNA.

          Polyadenylylated [poly(A)+] mRNA from HeLa cells that were labeled with [3H-methyl]-methionine and 14C-uridine was isolated by poly(U)-Sepharose chromatography. The presence of approximately two methyl groups per 1000 nucleotides of poly(A)+ RNA was calculated from the 3H/14C ratios and known degrees of methylation of 18S and 28S ribosomal RNAs. All four 2'-O-methylribonucleosides, but only two base-methylated derivatives, 7-methylguanosine (7MeG) and 6-methyladenosine (6MeA), were identified. 6MeA was the major component accounting for approximately 50% of the total methyl-labeled ribonucleosides. 7MeG, comprising about 10% of the total, was present exclusively at the 5' terminus of the poly(A)+ RNA and could be removed by periodate oxidation and beta elimination. Evidence for a 5' to 5' linkage of 7MeG to adjacent 2'-O-methylribonucleosides through at least two and probably three phosphates to give structures of the type 7MeG5'ppp5pNMep- and 7MeG5'ppp5'NMepNmep- was presented. The previous finding of similar sequences of methylated nucleotides in mRNA synthesized in vitro by enzymes associated with virus cores indicates that blocked 5' termini may be a characteristic feature of mRNAs that function in eucaryotic cells.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells.

            N6-methyladenosine (m6A) represents one of the most common RNA modifications in eukaryotes. Specific m6A writer, eraser, and reader proteins have been identified. As an m6A eraser, ALKBH5 specifically removes m6A from target mRNAs and inactivation ofAlkbh5leads to male infertility in mice. However, the underlying molecular mechanism remains unknown. Here, we report that ALKBH5-mediated m6A erasure in the nuclei of spermatocytes and round spermatids is essential for correct splicing and the production of longer 3'-UTR mRNAs, and failure to do so leads to aberrant splicing and production of shorter transcripts with elevated levels of m6A that are rapidly degraded. Our study identified reversible m6A modification as a critical mechanism of posttranscriptional control of mRNA fate in late meiotic and haploid spermatogenic cells.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Updates on Management of Gastric Cancer

                Bookmark

                Author and article information

                Contributors
                Journal
                Front Oncol
                Front Oncol
                Front. Oncol.
                Frontiers in Oncology
                Frontiers Media S.A.
                2234-943X
                18 October 2019
                2019
                : 9
                : 1038
                Affiliations
                [1] 1Department of Thoracic Surgery, Renmin Hospital of Wuhan University , Wuhan, China
                [2] 2Division of Cardiothoracic Surgery, Central Hospital of EnShi Tujia and Miao Autonomous Prefecture, EnShi Clinical College of Wuhan University , EnShi, China
                [3] 3Department of Pathology, Renmin Hospital of Wuhan University , Wuhan, China
                Author notes

                Edited by: Sungsoo Park, Department of Surgery, College of Medicine, Korea University, South Korea

                Reviewed by: Ye Fu, Harvard University, United States; Fiona McMurray, University of Ottawa, Canada

                *Correspondence: Jichang Hu hujichang@ 123456whu.edu.cn

                This article was submitted to Gastrointestinal Cancers, a section of the journal Frontiers in Oncology

                Article
                10.3389/fonc.2019.01038
                6813557
                31681576
                6cf5ed53-cfd0-4139-988e-2d340c8a22db
                Copyright © 2019 Su, Huang and Hu.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 17 July 2019
                : 24 September 2019
                Page count
                Figures: 6, Tables: 0, Equations: 0, References: 40, Pages: 10, Words: 5609
                Categories
                Oncology
                Original Research

                Oncology & Radiotherapy
                gastric cancer,m6a,tcga,epigenetic modification,fto
                Oncology & Radiotherapy
                gastric cancer, m6a, tcga, epigenetic modification, fto

                Comments

                Comment on this article